مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,398
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

223
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

IN VITRO INDUCTION OF FETAL HEMOGLOBIN IN ERYTHROID CELLS DERIVED FROM CD133+ CELLS BY TRANSFORMING GROWTH FACTOR- β AND STEM CELL FACTOR

Pages

  157-163

Keywords

CD133+ CELLSQ3
SCFQ3

Abstract

 Increased FETAL HEMOGLOBIN (HbF) in b-globin gene disorders ameliorates the clinical symptoms of the underlying disease. 5-azacytidine, butyrate and hydroxyurea, have been shown to activate g -globin gene expression. It has also been found that hematopoietic growth factors can influence expression of g-globin in erythroid cultures and in animal models. This study was designed to evaluate the in vitro effects of the stem cell factor (SCF) and transforming growth factor-b (TGF-b) on g-globin gene reactivation of erythroid precursors derived from CD133+ cells in vitro. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) analysis showed increased expression of the  g-globin transcript in cell culture groups containing either TGF- b or SCF or both as compared to control (2.2-, 2.7- and 5.5-fold, respectively) (p<0.01). Production of HbF in a differentiated population was demonstrated using flow cytometry. The results of this study suggest that SCF and TGF-b warrant further evaluation as potential therapeutic drugs for the treatment of b-globin gene disorders.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    ATASHI, AMIR, SOLEYMANI, MASOUD, KAVIANI, SAEID, HAJFATH ALI, A., & AREFIAN, E.. (2008). IN VITRO INDUCTION OF FETAL HEMOGLOBIN IN ERYTHROID CELLS DERIVED FROM CD133+ CELLS BY TRANSFORMING GROWTH FACTOR- β AND STEM CELL FACTOR. IRANIAN JOURNAL OF BIOTECHNOLOGY, 6(3), 157-163. SID. https://sid.ir/paper/139326/en

    Vancouver: Copy

    ATASHI AMIR, SOLEYMANI MASOUD, KAVIANI SAEID, HAJFATH ALI A., AREFIAN E.. IN VITRO INDUCTION OF FETAL HEMOGLOBIN IN ERYTHROID CELLS DERIVED FROM CD133+ CELLS BY TRANSFORMING GROWTH FACTOR- β AND STEM CELL FACTOR. IRANIAN JOURNAL OF BIOTECHNOLOGY[Internet]. 2008;6(3):157-163. Available from: https://sid.ir/paper/139326/en

    IEEE: Copy

    AMIR ATASHI, MASOUD SOLEYMANI, SAEID KAVIANI, A. HAJFATH ALI, and E. AREFIAN, “IN VITRO INDUCTION OF FETAL HEMOGLOBIN IN ERYTHROID CELLS DERIVED FROM CD133+ CELLS BY TRANSFORMING GROWTH FACTOR- β AND STEM CELL FACTOR,” IRANIAN JOURNAL OF BIOTECHNOLOGY, vol. 6, no. 3, pp. 157–163, 2008, [Online]. Available: https://sid.ir/paper/139326/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button